Skip to main content
. 2022 Aug 31;10(9):2129. doi: 10.3390/biomedicines10092129

Figure 2.

Figure 2

Annual rate of decline in FVC (mL per year) in IPF and SSc-ILD patients. FVC, forced vital capacity; IPF, idiopathic pulmonary fibrosis; SSc-ILD, systemic-sclerosis-associated interstitial lung disease.